Impact of Sitagliptin on Endometrial Mesenchymal Stem-Like Progenitor Cells: A Randomised, Double-Blind Placebo-Controlled Feasibility Trial

MLA

Maria J. Costa, et al. “Impact of Sitagliptin on Endometrial Mesenchymal Stem-Like Progenitor Cells: A Randomised, Double-Blind Placebo-Controlled Feasibility Trial.” SSRN Electronic Journal, Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c11c9c117b4690bb765727d00b79fe78&authtype=sso&custid=ns315887.

APA

Maria J. Costa, Satoru Takeda, Peter K. Kimani, Jan J. Brosens, Paul J. Brighton, Siobhan Quenby, Shreeya Tewary, Risa Fujihara, Katherine J. Fishwick, Angela Polanco, Emma S. Lucas, Joanne Muter, Lauren J. Ewington, & Lauren Lacey. (2019). Impact of Sitagliptin on Endometrial Mesenchymal Stem-Like Progenitor Cells: A Randomised, Double-Blind Placebo-Controlled Feasibility Trial. SSRN Electronic Journal.

Chicago

Maria J. Costa, Satoru Takeda, Peter K. Kimani, Jan J. Brosens, Paul J. Brighton, Siobhan Quenby, Shreeya Tewary, et al. 2019. “Impact of Sitagliptin on Endometrial Mesenchymal Stem-Like Progenitor Cells: A Randomised, Double-Blind Placebo-Controlled Feasibility Trial.” SSRN Electronic Journal, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c11c9c117b4690bb765727d00b79fe78&authtype=sso&custid=ns315887.